scispace - formally typeset
B

Brian M. Alexander

Researcher at Foundation Medicine

Publications -  275
Citations -  13384

Brian M. Alexander is an academic researcher from Foundation Medicine. The author has contributed to research in topics: Cancer & Lung cancer. The author has an hindex of 50, co-authored 264 publications receiving 9200 citations. Previous affiliations of Brian M. Alexander include Harvard University & University of Michigan.

Papers
More filters
Journal ArticleDOI

TIMI Frame Count A Quantitative Method of Assessing Coronary Artery Flow

TL;DR: The CTFC is a simple, reproducible, objective and quantitative index of coronary flow that allows standardization of TIMI flow grades and facilitates comparisons of angiographic end points between trials.
Journal ArticleDOI

Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials

TL;DR: The current document outlines consensus recommendations for a standardized Brain Tumor Imaging Protocol (BTIP), along with the scientific and practical justifications for these recommendations, resulting from a series of discussions between various experts involved in aspects of neuro-oncology neuroimaging for clinical trials.
Journal ArticleDOI

Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions

TL;DR: Novel therapies such as targeted molecular therapies, agents targeting DNA damage response and metabolism, immunotherapies and viral therapies will be reviewed, as well as the current challenges and future directions for research.
Journal ArticleDOI

Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study.

TL;DR: Generalizable estimates of the incidence and prognosis for patients with brain metastases at diagnosis of a systemic malignancy are provided to allow for appropriate utilization of brain-directed imaging as screening for subpopulations with cancer and have implications for clinical trial design and counseling of patients regarding prognosis.